Clark Estates Inc Amgen Inc Transaction History

Clark Estates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $4.17 Million - $4.61 Million	-19,025 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $4,972 - $5,690	25 Added 0.13%	19,025 $4.28 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $424,540 - $497,400	2,000 Added 11.76%	19,000 $4.04 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $3.77 Million - $4.4 Million	17,000 New	17,000 $4.23 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $2.89 Million - $3.21 Million	-12,300 Closed	0 $0

Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $1.23 Million - $1.5 Million	-6,200 Reduced 33.51%	12,300 $2.9 Million
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $3.08 Million - $3.62 Million	18,500 New	18,500 $3.41 Million

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

Stay updated on Clark Estates Inc with notifications on news.